Kapil Bharti

Company: National Institute of Health Science

Job title: Senior Investigator

Seminars:

A Phase 1/2a Study Using Autologous iPSC-Derived Retinal Pigment Epithelium for Treatment of Advanced Dry Age Related Macular Degeneration 9:30 am

What is the biological need for RPE replacement as a potential therapy for AMD? How to translate an autologous iPSC-based therapy from bench-to-bedside? What are the future disease specific applications of a RPE-based cell therapy?Read more

day: Conference Day One

Improving Regulatory & Clinical Strategies Going Forward to Pave the Way for iPSC Next Steps 8:35 am

A deep-dive session, providing insights from industry leader, Kapil Bharti, reflecting on his experience with moving to the clinic and detail learnings that can be drawn upon as the clinical pipeline progresses Join to: Benchmark data package requirements for regulatory strategies to facilitate a successful move to IND readiness stage Clarify data package requirements to…Read more

day: Pre-Conference Day